McAlpine's Multiple Sclerosis

5th Auflage
ISBN: 978-0-323-93634-7
Verlag: Elsevier Health Sciences

Buch, Englisch, 1000 Seiten, Format (B × H): 216 mm x 276 mm, Gewicht: 449 g

For more than 70 years, McAlpine's Multiple Sclerosis has been the gold standard textbook on the science and clinical practice of MS. The 5th Edition of this classic, landmark text reflects recent advances in this complex field, bringing you up to date with current information on genetics, epidemiology, clinical neurology, pathogenesis, and management of this common neurological disease. Easy to read and abundantly illustrated, this updated reference is a must-have resource for neurologists, neuropathologists, neurophysiologists, researchers, PM&R specialists, and others who can benefit from authoritative, comprehensive coverage of both scientific and clinical aspects of MS. - Discusses recent advances in both diagnosis and management, including improved understanding of MS in childhood and the elderly, anti-MOG disease, treatments of progressive MS, remyelination and neuroprotective therapies, and more
- Offers authoritative reviews of the current literature, placed in historical context
- Features more than 550 high-quality illustrations clarifying important scientific and clinical concepts
- Provides the most authoritative and comprehensive history of the understanding of the disease
- Uses a remarkably clear presentation to make complicated data easier to understand
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Autoren/Hrsg.

Coles, Alasdair

Compston, Alastair

Lassmann, Hans

Lubetzki, Catherine

Rocca, Maria A

Vucic, Steve

Weinshenker, Brian

Yong, V. Wee

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft

Inhaltsverzeichnis

1. The story and iconography of MS
2. The course and cost of MS
3. Definition of progressive MS
4. Health economics of MS and its treatment
5. The clinical features and diagnosis of MS
6. The prodrome of MS
7. MS in children and the elderly
8. Assessment of the eye in MS
9. Neuromyelitis opcitca and anti-MOG disease
10. The pathogenesis of MS
11. The treatment of MS
12. Models of care for the patient with MS
13. Monitoring the treatment of MS?

Über Autor(innen)

Coles, Alasdair
Alasdair Coles, Ph.D. is a Professor of Neuroimmunology in the Division of Clinical Neurosciences at the University of Cambridge. Has been doing MS research in Cambridge since 1994. He is also a consultant neurologist. With Alastair Compston, he was very involved in the development of alemtuzumab as a treatment of MS. He is employed as a senior lecturer by Cambridge University and has a small research team managing clinical trials and doing human immunological laboratory work. He does clinical work for two days a week as a consultant neurologist at Addenbrooke's and Peterborough Hospitals, is one of the medical advisers to the Multiple Sclerosis Society of the UK, and advises several pharmaceutical companies.

Weinshenker, Brian
Brian G. Weinshenker, MD, is a professor of neurology at the University of Virginia. He arrived at UVA Health's neurology department in 2022 after 35 years of experience practicing, including 30 years as a neurologist at the Mayo Clinic in Rochester, MN.

Compston, Alastair
Alastair Compston, PhD is Emeritus Professor of Neurology in the Division of Clinical Neurosciences at the University of Cambridge. Compston's research focuses on the clinical science of human demyelinating disease including the discovery of genetic risk factors for multiple sclerosis and the introduction of alemtuzumab. Compston was formerly Professor of Neurology at the University of Wales, president of the European Neurological Society and the Association of British Neurologists, and editor of the journal Brain. Compston's work has been recognised by prizes including the Charcot Award; the K-J Zülch Prize; the World Federation of Neurology Medal; the John Dystel Prize; the Richard and Mary Cave Award of the Multiple Sclerosis Society of Great Britain; the Hughlings Jackson Medal; the Galen Medal; and the Association of British Neurologists Medal. Compston was elected a Fellow of the Royal Society (FRS) in 2016and appointed Commander of the Order of the British Empire (CBE) in the 2016 New Year Honours.

Yong, V. Wee
V. Wee Yong, PhD, is a professor of translational neuroscience at the Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary. He co-directs the Multiple Sclerosis (MS) Program of the Hotchkiss Brain Institute, and he holds the Canada Research Chair in Neuroimmunology.

Lubetzki, Catherine
Catherine Lubetzki, MD, PhD, is a professor of neurology at the Pierre and Marie Curie University as well as head of the Department of Neurological Diseases at the Salpêtrière Hospital. She coordinates the Clinical Research Centre for Multiple Sclerosis at Salpêtrière.